Authors:
TECLE H
BARRETT SD
LAUFFER DJ
AUGELLISZAFRAN C
BRANN MR
CALLAHAN MJ
CAPRATHE BW
DAVIS RE
DOYLE PD
EUBANKS D
LIPINISKI W
MIRZADEGAN T
MOOS WH
MORELAND DW
NELSON CB
PAVIA MR
RABY C
SCHWARZ RD
SPENCER CJ
THOMAS AJ
JAEN JC
Citation: H. Tecle et al., DESIGN AND SYNTHESIS OF M1-SELECTIVE MUSCARINIC AGONISTS - (R)-(-)-(Z)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-(3'-METHOXYPHENYL)-2-PROPYNYL)OXIME MALEATE (CI-1017), A FUNCTIONALLY M1-SELECTIVE MUSCARINIC AGONIST, Journal of medicinal chemistry, 41(14), 1998, pp. 2524-2536
Citation: Cj. Spencer et al., A CENTRAL COMPOSITE ROTATABLE ANALYSIS FOR THE CATALYZED HYDROGEN-PEROXIDE REMEDIATION OF DIESEL-CONTAMINATED SOILS, Journal of the Air & Waste Management Association [1995], 46(11), 1996, pp. 1067-1074
Authors:
ORTEGA AE
PETERS JH
INCARBONE R
ESTRADA L
EHSAN A
KWAN Y
SPENCER CJ
MOOREJEFFRIES E
KUCHTA K
NICOLOFF JT
Citation: Ae. Ortega et al., A PROSPECTIVE RANDOMIZED COMPARISON OF THE METABOLIC AND STRESS HORMONAL RESPONSES OF LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY, Journal of the American College of Surgeons, 183(3), 1996, pp. 249-256
Authors:
SCHWARZ RD
SPENCER CJ
JAEN JC
MIRZADEGAN T
MORELAND D
TECLE H
THOMAS AJ
Citation: Rd. Schwarz et al., MUTATIONS OF ASPARTATE-103 IN THE HM2 RECEPTOR AND ALTERATIONS IN RECEPTOR-BINDING PROPERTIES OF MUSCARINIC AGONISTS, Life sciences, 56(11-12), 1995, pp. 923-929
Authors:
SPENCER CJ
SCHWARZ RD
MORELAND DW
THOMAS AJ
TECLE H
Citation: Cj. Spencer et al., EFFECT OF MUTATING ASPARTATE-103 TO GLUTAMATE OR ASPARAGINE IN THE HM2 SUBTYPE ON FINDING OF AGONISTS AND ANTAGONISTS OF VARIED PK(A) AND SUBTYPE SELECTIVITY, Life sciences, 56(11-12), 1995, pp. 1020-1020
Citation: Cj. Spencer, PEARLS AND ADORNMENT - DISCOURSE ON DISPL AY IN LAFAYETTE,MARIE,MADELEINE,DE LA 'PRINCESSE DE CLEVES', XVIIe siecle, (181), 1993, pp. 733-745